These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 2007294

  • 1. Echocardiographic findings in hemodialysis patients treated with recombinant human erythropoietin: proposal for a hematocrit most beneficial to hemodynamics.
    Tagawa H, Nagano M, Saito H, Umezu M, Yamakado M.
    Clin Nephrol; 1991 Jan; 35(1):35-8. PubMed ID: 2007294
    [Abstract] [Full Text] [Related]

  • 2. Hemodynamic and volume changes by recombinant human erythropoietin (rHuEPO) in the treatment of anemic hemodialysis patients.
    Hori K, Onoyama K, Iseki K, Fujimi S, Fujishima M.
    Clin Nephrol; 1990 Jun; 33(6):293-8. PubMed ID: 2376091
    [Abstract] [Full Text] [Related]

  • 3. Cardiovascular hemodynamic effects of correction of anemia of chronic renal failure with recombinant-human erythropoietin.
    Schwartz AB, Prior JE, Mintz GS, Kim KE, Kahn SB.
    Transplant Proc; 1991 Apr; 23(2):1827-30. PubMed ID: 2053168
    [Abstract] [Full Text] [Related]

  • 4. Echocardiographic findings in patients on maintenance hemodialysis substituted with recombinant human erythropoietin.
    Löw I, Grützmacher P, Bergmann M, Schoeppe W.
    Clin Nephrol; 1989 Jan; 31(1):26-30. PubMed ID: 2521587
    [Abstract] [Full Text] [Related]

  • 5. The cardiovascular and hemodynamic effects of erythropoietin in chronic renal failure.
    Singh NP, Chandrashekhar, Nair M, Anuradha S, Kohli R, Agarwal SK.
    J Assoc Physicians India; 2000 Mar; 48(3):301-6. PubMed ID: 11229114
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study.
    Pascual J, Teruel JL, Moya JL, Liaño F, Jiménez-Mena M, Ortuño J.
    Clin Nephrol; 1991 Jun; 35(6):280-7. PubMed ID: 1831414
    [Abstract] [Full Text] [Related]

  • 8. Haemodynamic changes and exercise tolerance in dialysis patients treated with erythropoietin.
    Jurić M, Rupcić V, Topuzović N, Jakić M, Brlosić R, Rusić A, Karner I, Stipanić S, Kes P.
    Nephrol Dial Transplant; 1995 Jun; 10(8):1398-404. PubMed ID: 8538932
    [Abstract] [Full Text] [Related]

  • 9. Impact of recombinant human erythropoietin treatment on left ventricular hypertrophy and cardiac function in dialysis patients.
    Massimetti C, Pontillo D, Feriozzi S, Costantini S, Capezzuto A, Ancarani E.
    Blood Purif; 1998 Jun; 16(6):317-24. PubMed ID: 10343078
    [Abstract] [Full Text] [Related]

  • 10. Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin.
    Silberberg J, Racine N, Barre P, Sniderman AD.
    Can J Cardiol; 1990 Jun; 6(1):1-4. PubMed ID: 2138048
    [Abstract] [Full Text] [Related]

  • 11. Could CAPD modulate the hemodynamic changes induced by rHuEPO treatment?
    Fernández A, Vega N, Hortal L, Jimenez F, Laraudogoitía E, Macía M, Plaza C, Perdomo M, Palop L.
    Adv Perit Dial; 1992 Jun; 8():435-9. PubMed ID: 1361842
    [Abstract] [Full Text] [Related]

  • 12. [Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients].
    Jalil R, Vaccarezza A, Jara A, Lira P, Vial S, Serrano V.
    Rev Med Chil; 1990 Jun; 118(6):629-34. PubMed ID: 1775783
    [Abstract] [Full Text] [Related]

  • 13. Iron balance following recombinant human erythropoietin therapy for anemia associated with chronic renal failure.
    Hotta T, Ogawa H, Saito A, Ito A.
    Int J Hematol; 1991 Jun; 54(3):195-200. PubMed ID: 1747454
    [Abstract] [Full Text] [Related]

  • 14. Long-term myocardial effects of correction of anemia with recombinant human erythropoietin in aged patients on hemodialysis.
    Martinez-Vea A, Bardají A, García C, Ridao C, Richart C, Oliver JA.
    Am J Kidney Dis; 1992 Apr; 19(4):353-7. PubMed ID: 1532883
    [Abstract] [Full Text] [Related]

  • 15. Hemodynamic effects of anemia correction by recombinant human erythropoietin in predialysis patients with renal failure.
    Sapojnikov M, Veksler A, Yagil Y, Kogan J, Turkot S, Boris G, Oren S.
    Ren Fail; 2005 Apr; 27(2):199-203. PubMed ID: 15807186
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin.
    Eschbach JW, Kelly MR, Haley NR, Abels RI, Adamson JW.
    N Engl J Med; 1989 Jul 20; 321(3):158-63. PubMed ID: 2747747
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of anemia in patients with chronic renal insufficiency undergoing hemodialysis with recombinant human erythropoietin: 12 months' experience].
    de Sousa FT, Prata MM, Barbas JV, dos Santos JP.
    Acta Med Port; 1990 Jul 20; 3(6):347-52. PubMed ID: 2089856
    [Abstract] [Full Text] [Related]

  • 19. The effect of recombinant human erythropoietin (r-HuEPO) on left ventricular mass and left ventricular hemodynamics in hemodialysis patients.
    Minagawa T, Hirano T, Takada N, Ishiguro M, Ohtsuka H.
    Nihon Jinzo Gakkai Shi; 1994 Aug 20; 36(8):934-41. PubMed ID: 7933670
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.